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Current evidence suggests that the nucleus has a distinct substructure, albeit one that
is dynamic rather than a rigid framework. Viral infection, oncogene expression, and
inherited human disorders can each cause profound and specific changes in nuclear
organization. This review summarizes recent progress in understanding nuclear orga-
nization, highlighting in particular the dynamic aspects of nuclear structure.
First described by Brown in 1831, the cell
nucleus is one of the best known but least
understood of cellular organelles. The struc-
ture and functional organization of the nu-
cleus remains a subject of energetic debate.
At one extreme, the nucleus has been pro-
posed to have its own nucleoskeleton and
distinct organelles. At the other, it is
viewed as a largely disordered, membrane-
bound bag of DNA and other molecules, in
which all “structures” are no more than
transient complexes that form and disperse
as a result of transcription, replication, and
RNA processing activities in various re-
gions of the genome. Understanding in
molecular detail the organizing principles
of the nucleus—including the arrangement
of chromosomal DNA and how the syn-
thesis, processing, assembly, and transport
of macromolecules are coordinated and
regulated—is a major goal for cell biology.
Compartments of the
Interphase Nucleus
In the interphase nucleus, individual chro-
mosomes occupy discrete patches referred to
as chromosome territories (1), which are sep-
arated by channels called the interchromo-
somal domain (Fig. 1). Active genes tend to
be preferentially localized to the periphery of
the chromosome territories (2, 3). RNA
transcripts are apparently formed preferen-
tially at the surface of the territories and are
then “shed” into interchromosomal domain
channels for further processing and trans-
port. Because the volume available to factors
involved in RNA transcription and process-
ing is thereby reduced (4), this process may
enhance the assembly of large macromolec-
ular transcription and splicing complexes.
This model predicts that, relative to less
active chromosomes, transcriptionally ac-
tive chromosomes might have more surface
area in contact with the channels. This has
been confirmed for human X chromosomes:
The volumes of the active and inactive X
chromosomes were shown to be essentially
identical (5), and the inactive X chromo-
some was apparently no more condensed
than the active X. Instead, the inactive X,
with far fewer active genes, had a much
reduced surface area relative to that of its
active counterpart.
Active and inactive regions are inter-
spersed along the length of the chromo-
somes but are segregated from one another
within the chromosome territories. When
highly synchronous populations of Chinese
hamster fibroblasts undergoing DNA rep-
lication were pulse-labeled for short pe-
riods with halogenated deoxyribonucleotide
triphosphates (dNTPs), early-replicating (R
band) DNA was found largely dispersed
throughout the nuclear interior, whereas
later-replicating (G band) DNA was con-
centrated near the nuclear periphery (6). A
similar arrangement of the chromosome fi-
ber was suggested by another study in which
fluorescence in situ hybridization (FISH)
was used to localize sequences distributed
across the long arm of chromosome 2 in
Drosophila embryo nuclei (7). Together,
these studies suggest that within individual
chromosome territories the chromatin fiber
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Fig. 1. (A) Chromosome-painting FISH performed under conditions where signal from repeated DNA
sequences is suppressed (120). Left, metaphase spread showing labeled human chromosomes 4.
Right,interphasenucleusshowingthetwochromosome4territories.(ImageprovidedbyT.Cremer.)(B)
The organization of chromosomes in the nucleus. Each chromosome occupies a discrete territory.
These territories are separated by the interchromosomal domain, in which it is believed that much RNA
processing and trafficking occurs. Within individual territories, the chromatin fiber appears to be looped,
with late-replicating DNA near the nuclear periphery and early-replicating DNA in the interior. (C and D)
Differential localization of the CD4 locus under expressing and nonexpressing conditions. In T cell line
VL3, where the CD4 gene is active (C), the gene was associated with gamma satellite in 1 of 57 nuclei.
In B cell line B3, where the CD4 gene is inactive (D), the gene was associated with gamma satellite in 52
of 52 nuclei. The CD4 locus and the gamma satellite are labeled with fluorescein isothiocyanate and
rhodamine, respectively. A single slice from a confocal Z-series is shown in each case. Scale bar, 2 mm.
[Image provided by K. Brown and A. Fisher (24).] (E) Diagram showing how the activation or repression
of the CD4 gene is correlated with movement of the gene relative to heterochromatin.
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between the nuclear interior and the pe-
riphery (Fig. 1). Because the G and R bands
are interleaved and immediately adjacent to
one another in mitotic chromosomes, their
segregation into different portions of the
chromosome territory in interphase must
involve the movement of large-scale chro-
mosome segments within the nucleus at the
completion of mitosis.
Chromosome Movements
Within the Nucleus
Two recent studies using fluorescence re-
covery after photobleaching (FRAP) yield-
ed different views of the nature of the nu-
cleoplasm. In one study, microinjected flu-
orescent dextrans and ficolls were found to
diffuse relatively unimpeded; a 500-kD
protein would diffuse from one side of a
10-mm nucleus to the other in only ;7s
(8). Because this rapid diffusion presuma-
bly occurs within interchromosomal do-
main channels, they may not be filled with
a mesh-like matrix of structural filaments,
as suggested by previous results (9). Chan-
nels that end at nuclear pores might func-
tion like “tracks” along which RNAs bound
for export could move (10).
A different result was obtained using the
FRAP method when chromatin was labeled
with a fluorescent dye and then bleached
with a laser. No movement was observed
over the next 60 to 80 min (11). Nonethe-
less, chromosomes and chromatin can move
within the nucleus. Centromere move-
ments in vivo were observed directly using
the DNA binding domain of human cen-
tromere protein CENP-B( 12) fused to
green fluorescent protein (GFP) (13). Indi-
vidual centromeres moved, albeit infre-
quently, over distances of a micrometer or
more at 7 to 10 mm per hour.
The chromosome arms also move during
interphase, as shown for a large chromo-
somal domain by tracking a lac repressor–
GFP fusion protein bound to an artificial
array containing thousands of lac operators
(14). This movement was cell cycle–depen-
dent; the domain moved from the nuclear
interior to the periphery during the G1
phase of the cycle, from the periphery into
the interior during S phase, and back to the
periphery again during G2. These move-
ments were accompanied by a cycle of con-
densation and decondensation.
Entire chromosome territories labeled
with the fluorescent thymidine analog Cy3-
AP3–deoxyuridine triphosphate have been
tracked in living cells (15). Two weeks after
microinjection of the tracer, the original
labeled chromosomes had been replicated
and segregated many times, leaving only
one or a few labeled chromatids in any one
cell. Four-dimensional (three-dimensional
over time) movies revealed movements at
three levels within these cells: (i) changes
in the position of entire chromosome terri-
tories with respect to one another by dis-
tances of several micrometers over a time
scale of 2 to 3 hours; (ii) movement of
subchromosomal foci, 400 to 800 nm in
diameter, within territories; and (iii) flex-
ations of the chromatin fiber within the
subchromosomal foci (15). The mechanism
is unknown but may involve mechano-
chemical motor proteins such as chromoki-
nesin (16) or nod (17), action of tethered
RNA polymerases (18), localized alter-
ations in chromosome condensation, or
electrostatic gradients within the nucleus
(4).
Why do chromosomes move? Some
movements may be linked to DNA replica-
tion, consistent with the proposal that
DNA replication occurs at a fixed number
of sites within the nucleus, termed “replica-
tion factories” (19). Such sites are suggested
to contain large multienzyme complexes
that do not move within the nucleus; rath-
er, chromosomes move to the factories to
initiate their replication (20).
How Heterochromatin Can
Regulate Gene Expression
Heterochromatin contains relatively few
genes, replicates during late S phase, is en-
riched in specific nuclear proteins, and can
suppress the transcriptional activity of ac-
tive genes that are translocated adjacent to
it (21). When genes that normally reside in
euchromatin are translocated near to cen-
tromeres or telomeres, transcription is de-
creased. This “position effect” is driven by
heterochromatin proteins, for which more
than 50 candidates have so far been report-
ed in Drosophila alone.
Two recent studies on the Browndominant
(BwD) mutant in Drosophila show that gene
silencing by heterochromatin can involve
the movement of the silenced gene from
one area of the nucleus to another. BwD has
an insertion of ;2 Mb of AAGAG satellite
DNA into the Brown locus, located in eu-
chromatin near the end of the long arm of
chromosome 2 (22). In BwD/1 flies, the
expression of the wild-type allele is only
;2% of normal. FISH analysis revealed
that BwD and Bw1 preferentially associate
with one another and with centromeric
heterochromatin of chromosome 2 (23),
thereby bringing the Bw1 gene into prox-
imity with the centromere and transcrip-
tionally inactivating it. This somatic pair-
ing of homologs, which drives the inactiva-
tion of Bw1 expression, is not observed in
mammals. However, recent evidence sug-
gests that a similar “recruitment” model for
gene inactivation by heterochromatin may
also be valid in mammals.
Ikaros is a transcriptional regulator es-
sential for lymphoid development. When
six transcriptionally active and inactive
genes were localized in mouse pre-B and
mature B cell lines, the inactive genes were
invariably recruited to sites of Ikaros local-
ization at centromeric heterochromatin
(24). In contrast, active genes were local-
ized elsewhere in the nucleoplasm (Fig. 1).
These results provide a striking correlation
between gene position within the nucleus
and transcriptional activity, and they sug-
gest that Ikaros may transcriptionally inac-
tivate genes by “recruiting” them from per-
missive loci in the nucleoplasm to a zone of
transcriptional suppression near centromer-
ic heterochromatin. Together, these results
in Drosophila and mouse cells lend strong
support to the notion that gene silencing by
heterochromatin involves the movement of
chromosomal loci to a functionally discrete
nuclear compartment in which gene tran-
scription is actively suppressed.
The Polycomb Group (PcG)
Domain: A Euchromatin
Silencing Domain?
Heterochromatin is thought to contain
large protein complexes that propagate lat-
erally along the chromatin fiber and silence
genes with which they come into contact
(25). This mechanism can explain the si-
lencing of genes that are transposed near to
the telomeres of yeast chromosomes (21),
which requires the formation of a complex
between the silent information regulators
SIR3 and SIR4, repressor activator protein
RAP1, and core histones (26).
The best known heterochromatin pro-
tein in higher eukaryotes, HP1 (hetero-
chromatin protein 1), was identified in a
screen for monoclonal antibodies that
stained Drosophila polytene chromosomes
(27). HP1 shares an ;50–amino acid
NH2-terminal sequence motif, the chromo
domain, with polycomb, an important reg-
ulatory gene that functions in the stable
repression of homeotic genes during Dro-
sophila development (28). A second
chromo domain–like motif, the chro-
moshadow domain, located near the HP1
COOH-terminus (29), appears to be a key
element in the assembly of multiprotein
complexes in heterochromatin.
Emerging evidence suggests that HP1 is
a structural adapter whose role is to assem-
ble macromolecular complexes in chroma-
tin. HP1 interacts with multiple nuclear
proteins, including itself (30); the lamin B
receptor, an integral protein of the inner
nuclear envelope (31); BRG1/SNF2b, a
component of the SWI/SNF complex that
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tors in transcriptional activation (30); nu-
clear receptor cofactor TIF1-a, a protein
that interacts with the ligand-dependent
activation domain of steroid hormone re-
ceptors (30); bLAP, a leucine amino pep-
tidase (30); a RAD54-like presumed heli-
case (30); the product of the Su(var)3-7
gene, a heterochromatin protein of un-
known function (32); Orc1 and Orc2, two
members of the origin recognition com-
plex, a hexamer that binds to origins of
replication and is essential for the initia-
tion of DNA replication (33); and SP100,
a major component of PML nuclear bodies
(see below) (34). Targeting of HP1 to
reporter genes inactivates transcription
(30, 34). The role of most of these inter-
actions is unknown, but localization of
heterochromatin at the inner surface of
the nuclear envelope may, at least in part,
be explained by the lamin B receptor–HP1
interaction (31).
The Polycomb protein is also involved
in gene silencing, although it binds exclu-
sively to sites in euchromatin (35). Four
cloned human Polycomb group members
(36) can interact with one another and
colocalize in 10 to 20 nuclear domains of
unknown function, termed PcG domains.
These are distinct from PML nuclear bod-
ies, interchromatin granule speckles, and
centromeric heterochromatin (see below).
PcG domains may represent silencing com-
partments for the inactivation of specific
genes in euchromatin. Because a dominant
negative Polycomb mutant specifically de-
represses c-myc expression in human and rat
cell lines, it will be interesting to see wheth-
er the c-myc gene resides in or near PcG
domains when in its basal state.
The Nucleolus
The nucleolus is formed around the ribo-
somal DNA (rDNA) repeats, which cluster
at chromosomal loci called nucleolar orga-
nizers, and is the factory in which 28S,1 8 S,
and 5.8S ribosomal RNAs (rRNAs) are
transcribed, processed, and assembled into
ribosome subunits (Fig. 2). Nucleolus for-
mation is both transcription- and cell cy-
cle–dependent: In most eukaryotic cells,
the entire structure breaks down and re-
forms during each mitotic cycle. Thus, the
nucleolus is a dynamic structure that forms
in response to the requirement for new
ribosome synthesis.
Within the nucleolar factory, the rRNA
is extensively modified during ribosome
biogenesis in a process involving a series of
specific nucleolytic cleavages as well as base
modifications to introduce ;100 29-O-
methyl ribose and ;90 pseudouridine resi-
dues per molecule (37). Small nucleolar
ribonucleoproteins (snoRNPs) have been
shown to act as “guide RNAs” during rRNA
maturation (38), targeting sites of 29-O-
methyl ribose and pseudouridine formation
[D box and ACA snoRNPs, respectively
(39)] and directing nucleolytic cleavage of
the rRNA precursor [U3, U8, U14, and
U22 snoRNPs (38)]. Small nucleolar RNAs
can be engineered to target 29-O-methyl-
ation to regions of RNA that are normally
unmodified (40). This approach should
have important applications for studying
how RNA modification influences RNA
function.
In addition to its major role in ribo-
some production, the nucleolus may also
be involved in messenger RNA (mRNA)
export or degradation. This was first sug-
gested by the observation that inactivat-
ing nucleoli by ultraviolet irradiation pre-
vented the export of nonribosomal RNAs
in mammalian cells (41). Although bulk
polyadenylate [poly(A)] mRNA does not
localize in nucleoli in higher eukaryotes,
specific transcripts, including MyoD and
N-myc, have been detected in nucleoli
(42). Furthermore, interference with
mRNA transport by mutation of the
mtr1-1 and mtr2-1 genes of Saccharomyces
cerevisiae (43) or severe heat shock in S.
pombe (44) results in the accumulation of
poly(A) RNA in the nucleolus.
The existence of the newly described
perinucleolar compartment (PNC) in 10 to
50% of cells (depending on cell type) also
raises the possibility of further functions
associated with nucleoli. The PNC contains
several RNA polymerase III
transcripts and the hnRNPI pro-
tein (also called PTB) (45). Targeting of
hnRNPI to the PNC requires the presence
of specific RNA binding domains (46). The
function of the PNC is unclear at present.
As discussed below, the nucleolus also in-
teracts with coiled bodies (see Fig. 2). Thus,
despite the long history of nucleolar re-
search, the nucleolus may still have some
secrets left to divulge.
Speckles, snRNPs, and
Punctate Patterns
Many nuclear factors localize either partly
or completely in distinct “bodies” or sub-
nuclear compartments that produce a punc-
tate staining pattern when analyzed by in-
direct immunofluorescence (Fig. 3). Inter-
est in these subnuclear bodies has been
rekindled by recent discoveries that some of
them contain factors involved in the pro-
cessing and transcription of RNA and that
in several cases both subnuclear bodies and
the factors they contain are intimately
linked with human disease.
The U1, U2, U4/U6, and U5 small nu-
clear ribonucleoproteins (snRNPs) are nu-
cleoplasmic RNA-protein complexes that
function as subunits of the spliceosome,
which removes introns from nuclear mRNA
precursors. Antibodies that stain snRNPs
show punctate (“speckled”) labeling against
a more diffuse background of nucleoplasmic
staining (47). The diffuse staining is largely
attributable to snRNPs interacting with
Fig. 2. Electron micro-
graphs showing (A) a cross
section of a mammalian cell
nucleus, (B) higher magnifi-
cation view of the nucleolus,
and (C) a coiled body (CB)
attached to the nucleolar
periphery. The nucleolus (as-
terisk in each panel) is
differentiated into the fibril-
lar center (FC), dense fibril-
lar component (DFC), and
granular component (GC),
although there is heteroge-
neity in nucleolar morpholo-
gy between different cell
types and under different
growth conditions and nu-
cleoli also frequently contain
heterochromatin and nucle-
oplasmic vacuoles (121).
The consensus view is that
the FCs contain rDNA, RNA
polymerase I, and associated transcription factors, with transcription of rDNA occurring largely at the
boundary between the FC and DFC. Nascent rRNA transcripts appear in the DFC and are processed
there. Some processing steps may also occur in the GC, together with the assembly of the rRNA into
ribosomal subunits. Arrowheads in (A) indicate peripheral heterochromatin. In (C), arrowheads point to
fibersconnectingthecoiledbodywiththenucleolus.Thissectionhasbeenimmunogold-labeledwithan
antibody to p80 coilin.
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transcription is inhibited. The speckled pat-
tern results from the association of snRNPs
with several structures previously visualized
by electron microscopy: clusters of dense
particles that contain aggregates of snRNPs
and other protein splicing factors (inter-
chromatin granules), found in the spaces
between more densely staining regions of
chromatin (47); interchromatin granule–as-
sociated zones that flank interchromatin
granules and contain U1, but not the other
splicing snRNPs (49); perichromatin fibrils
that are closely associated with active chro-
matin and contain newly transcribed
mRNA precursors and processed mRNA
(50); and coiled bodies that are fibrillar
structures, discussed below (51).
We use the term “speckles” specifically
to denote the interchromatin granule–re-
lated clusters of snRNP staining, and not
the overall punctate pattern that includes
diffuse nucleoplasmic staining and coiled
bodies. The importance of speckles is still
being debated; the speckled pattern may be
exaggerated by antibody labeling conditions
(52) or as a result of threshold effects during
image analysis (53). Nonetheless, inter-
chromatin granule speckles are genuine
nuclear structures that can be visualized
directly in the electron microscope. Speck-
les disperse when cells enter mitosis,
but snRNPs and protein splicing factors
reform into speckle-like structures dur-
ing telophase, before their reimport into
daughter nuclei (54, 55). Thus, snRNP
speckles can occur in the absence of DNA
and transcription.
Cells showing high transcription exhibit
more widespread nucleoplasmic localization
of RNA processing factors and less speckled
staining, whereas reduced transcription is
often accompanied by increased speckled
staining (56). The mRNA from some high-
ly transcribed genes is enriched near speck-
les (57, 58), suggesting a possible role in
mRNA transcription or maturation. How-
ever, speckles are not major sites of tran-
scription, which occurs in thousands of foci
throughout the nucleoplasm (3, 59–61).
Speckles do not incorporate either triti-
ated uridine or bromouridine triphosphate
(Br-UTP) during pulse-labeling experi-
ments and lack detectable DNA (3, 50,
59–61), but they do contain poly(A) RNA
[detected with poly(dT) or poly(U) oligo-
nucleotide probes (62)]. Speckles may thus
be involved in mRNA export (63), al-
though it is still unproven whether their
poly(A) RNA can be chased to the cyto-
plasm when transcription is blocked (58,
64, 65). An alternative scenario is that
speckles function either as depots supplying
splicing factors to active gene loci, or way
stations accumulating snRNPs bound either
to partially spliced pre-mRNA or to excised
introns after release of mRNA from the
spliceosome (53, 66). Some or all of the
speckle-associated poly(A) RNA could be
structural or aberrant, rather than mRNA
bound for export.
The localization of splicing factors is
dynamic and involves trafficking between
nuclear substructures. An elegant demon-
stration of this dynamic organization was
recently provided by visualizing the splicing
factor ASF (or SF2) fused to GFP in living
cells (67). It seems likely that mRNA pre-
cursors are transcribed and processed at ac-
tive gene loci dispersed throughout the nu-
cleoplasm and that snRNPs and other RNA
processing factors cycle between these tran-
scription sites and interchromatin granule
speckles. Such cycling may be regulated by
protein phosphorylation (66), because per-
turbation of both kinase and phosphatase
activities can cause changes in the degree of
punctate staining shown by splicing factors
(68). It remains to be established whether
the interchromatin granule speckles simply
store inactive factors or participate more
actively in one or more steps connected
with mRNA maturation and transport.
Coiled Bodies and Gems
Coiled bodies appear in the electron micro-
scope as a ball of tangled threads 0.15 to 1.5
mm in diameter (69). They disassemble dur-
ing mitosis and reform during G1 phase after
transcription is reinitiated (55, 70). The
coiled body is a highly dynamic structure
that may play a role in snRNP transport,
maturation, or both. Coiled bodies contain
spliceosomal snRNPs (71, 72) as well as
several nucleolar antigens, including fibril-
larin, NOPP140, and U3 snoRNP (73–75)
and a human autoantigen called p80 coilin
(76). Coilin is highly enriched in coiled
bodies (although it is also present in a dif-
fuse nucleoplasmic pool) and has been
widely used as a marker for the coiled body.
Coiled bodies vary in number from 1 to 10
or more; they are most prominent in rapidly
growing cells (77), and their protein com-
position may differ slightly in different cell
types (78).
Amphibian oocytes contain nuclear
bodies, originally called sphere organelles,
that have recently been described as resem-
bling coiled bodies. Like coiled bodies in
somatic cells, they contain splicing snRNPs
and a protein, called SPH-1, with signifi-
cant homology to p80 coilin (79). They
accumulate human p80 coilin when it is
expressed in Xenopus oocytes (80) and can
associate with histone gene loci, possibly
acting to supply U7 snRNP to these sites
(81). Spheres (or Xenopus coiled bodies)
can be assembled in vitro from Xenopus egg
extracts (82). Depletion studies show that
sphere-like bodies can assemble without
SPH-1, although SPH-1 and Sm proteins
may need to interact to allow their mutual
assembly into this structure (83).
The function of coiled bodies is still
unknown. They might be involved in reg-
ulating snRNA gene expression; in some
cell types, a striking spatial relation exists
between gene loci encoding certain U
snRNAs and a subset of nucleoplasmic
coiled bodies (72, 84). However, coiled
bodies are probably not sites of coordinated
snRNA transcription, processing, and as-
sembly, because they lack nascent RNA
and because snRNP particle assembly from
snRNA and Sm proteins occurs in the cy-
toplasm (85). Coiled bodies do not contain
DNA (86), and they are unlikely to be sites
of pre-mRNA transcription or splicing be-
cause they lack protein splicing factors such
as SC-35, nascent pre-mRNA, or poly(A)
mRNA (3, 50, 59–61, 64, 73, 74). Nor are
Fig. 3. Stereo view of a triple-labeled HeLa cell nucleus showing the localization of coiled bodies (green,
GFP-coilin), PML bodies (red, autoimmune serum recognizing SP100), and nucleoli (blue, anti-fibrillarin).
Scale bar, 5 mm.
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snRNPs, because when transcription and
splicing are blocked, coiled bodies disperse
and snRNPs concentrate instead in large
interchromatin granule speckles. Coiled
bodies may, however, play a role in histone
mRNA 39 processing, because they contain
the U7 snRNP that cleaves the 39 terminus
of histone pre-mRNA, and a subset of
coiled bodies are found adjacent to histone
gene loci in some cells (81, 87).
A key unexplained feature of coiled
bodies is their intimate relationship with
the nucleolus. In neuronal cells, which
undergo extensive transcription and splic-
ing, coiled bodies [originally called “nucle-
olar accessory bodies” (88)] are often very
large (.1 mm in diameter), and electron
microscopy studies have shown fibers con-
necting coiled bodies to the nucleolar pe-
riphery (Fig. 2). Coiled bodies have also
occasionally been observed within nucle-
oli of mammalian cells (89). The interac-
tion between coiled bodies and nucleoli
may be regulated by phosphorylation (90).
This morphological association of coiled
bodies and nucleoli appears to be of gen-
uine functional importance. When tran-
scription is inhibited, nucleoplasmic
coiled bodies disappear and p80 coilin
forms “caps” on the nucleolar periphery
(71, 72). The Wilms tumor protein WT1
also relocates into the same perinucleolar
caps when transcription is inhibited,
which suggests that it may play some role
connected with coiled bodies (91). Final-
ly, transient expression of a truncated p80
mutant can disrupt both coiled bodies and
nucleoli (but not interchromatin granule
speckles) (92).
Why should snRNPs and coiled bodies
interact with the nucleolus? Trafficking of
snRNPs to the nucleolus may be important
for snRNP maturation, because snRNAs re-
ceive many of the same modifications as
rRNA, including 2-O-methylation and
pseudouridine formation (51, 90). If the
nucleolar activities that modify rRNA also
modify snRNAs, coiled bodies may then act
as nuclear transport or sorting structures.
Coiled body–like structures called
“gems” (gemini of coiled body) (93) have
recently been shown to be paired fre-
quently with coiled bodies. Sometimes the
two structures overlap, and both are simi-
larly affected by cell growth temperature
and transcription inhibitors (93, 94).
Gems contain the SMN (survival of motor
neurons) protein, encoded by the gene
responsible for a severe inherited form of
human muscular wasting disease, spinal
muscular atrophy (93, 95). The SMN pro-
tein interacts with the Sm class of snRNP
proteins and (through a separate binding
site) with a cellular protein called SIP1
(96). The SMN-SIP1 complex plays an
essential role in cytoplasmic snRNP bio-
genesis (97). Mammalian SIP1 shows sig-
nificant homology to an S. cerevisiae gene
called Brr1, which, when mutated, impairs
snRNP biogenesis (98). Thus, defects in
spliceosomal snRNP assembly may be in-
volved in spinal muscular atrophy, and an
intranuclear snRNP trafficking pathway
may involve interactions between gems
and coiled bodies.
PML Nuclear Bodies
PML nuclear bodies [also known as PODs
(PML oncogenic domains), Kr bodies, and
ND10 (nuclear domain 10) (99, 100)] are
nuclear domains that are specifically dis-
rupted in human acute promyelocytic leu-
kemia (APL) cells. A typical mammalian
nucleus has ;10 to 20 PML bodies, which
vary in size from ;0.3 to 1 mm and are
tightly associated with the nuclear matrix.
The role of PML bodies is unknown. They
are not major sites of transcription, they
lack snRNPs and protein splicing factors,
and they contain little or no replicating
DNA during S phase (101, 102). Their
name derives from their most intensively
studied protein component, PML, which is
a RING-finger motif protein that was dis-
covered through analysis of the dominant
oncogene responsible for APL. The char-
acteristic t(15;17) chromosome transloca-
tion in APL cells fuses cellular PML to the
retinoic acid receptor alpha (RARa) gene
to form the oncoprotein PML-RARa
(103).
PML bodies in APL cells are disrupted
and replaced by a micropunctate pattern
in which PML, PML-RARa, and the ste-
roid receptor RXR ectopically associate in
many small nucleoplasmic foci (100, 101,
104). Few of these microfoci incorporate
Br-UTP, which suggests that their major
effect on gene expression may be to repress
transcription rather than activate it; how-
ever, it is possible that they stimulate tran-
scription at some loci. Remarkably, reti-
noic acid and arsenic trioxide, both of
which are used in clinical treatment of
APL patients (105, 106), induce reforma-
tion of PML bodies and trigger degra-
dation of PML-RARa in APL cells in
culture (100, 101, 104, 105, 107). This
points to an intimate relationship between
nuclear organization in APL blasts and the
malignant phenotype.
In addition to PML protein, PML bodies
contain the autoantigen SP100 (108) and
may also contain the LIM-motif protein
NDP52 (109), although this has been dis-
puted (110). All three proteins are up-reg-
ulated upon interferon treatment (109,
111). Several viral proteins also associate
with PML bodies; infection with
herpes simplex virus–type 1
(HSV-1), adenovirus, and human cytomeg-
alovirus disrupts PML bodies, which sug-
gests that they may play some role in cellu-
lar antiviral defense (112). The HSV-1i m -
mediate early gene product Vmw110 (also
called ICP0) associates with PML bodies at
an early stage of HSV-1 infection. This
protein strongly activates the transcription
of many genes in transient transfection as-
says, and mutations in the Vmw110 gene
severely reduce the ability of HSV-1t o
mount a lytic infection (113). Vmw110
interacts with a cellular protein called
HAUSP, which is a member of the ubiq-
uitin-specific protease family (114). In un-
infected cells, HAUSP shows a diffuse nu-
cleoplasmic localization, excluding nucleo-
li, and also labels punctate structures, some
of which colocalize with a subset of PML
bodies. After HSV-1 infection, HAUSP
concentrates prominently in PML bodies,
presumably targeted through its interaction
with Vmw110.
The PML protein exists in two forms: in
a “free” form that is dispersed throughout the
nucleoplasm, and as a conjugate with the
ubiquitin-like protein SUMO1 [small ubiq-
uitin-like modifier, also called PIC1 (115)]
(107, 116). The PML-SUMO1 conjugate is
exclusively localized to PML bodies, suggest-
ing that linkage of PML to SUMO1 may
either stabilize or promote the assembly of
PML bodies. Consistent with this idea, treat-
ment of cultured cells with arsenic trioxide
promotes multi-SUMO1 conjugates to PML
and concomitantly enhances PML body for-
mation (107). SUMO1 conjugation is re-
versible and may be regulated by protein
phosphorylation.
There is a recent precedent for SUMO1
conjugation promoting association of a sol-
uble protein with a nuclear structure. The
protein RanGAP1 is a cytoplasmic guano-
sine triphosphatase (GTPase)–activating
factor for the small GTPase Ran that func-
tions in protein transport through the nu-
clear pore complex. Although cytoplasmic
RanGAP1 is unmodified, a fraction of Ran-
GAP1 that is conjugated to SUMO1 is
specifically localized to the nuclear pore
complex, where it interacts with the nucle-
ar pore protein RanBP2 (or Nup358) (117).
SUMO1 is linked to RanGAP1 by a specif-
ic lysine residue (Lys526), and the SUMO-
conjugated form of RanGAP1 remains sta-
bly associated with the nuclear pore com-
plexes during multiple cycles of protein im-
port. For both RanGAP1 and PML,
conjugation to SUMO1 appears to direct
protein localization rather than degrada-
tion. Posttranslational conjugation with
SUMO1, and perhaps with other members
of the ubiquitin-related protein family, may
www.sciencemag.org z SCIENCE z VOL. 280 z 24 APRIL 1998 551thus be a general mechanism for direct-
ing protein assembly into specific nuclear
structures.
Perspectives
The development of new microscopy tech-
niques and methodologies for analyzing
chromosomes and the localization of nucle-
ar factors has helped to stimulate a resur-
gence of interest in studying the functional
organization of the nucleus. For example,
chromosome-painting FISH (Fig. 1) has
revolutionized clinical cytogenetics by facil-
itating the mapping of chromosome break-
points and rearrangements in metaphase
chromosome spreads (118). Single mRNA
transcripts can also now be detected in situ
with the use of oligodeoxynucleotide probes
containing five fluorochromes per mole-
cule, hence allowing quantitative analysis
of transcription from individual gene loci
(119). However, we still have only a rudi-
mentary knowledge of how chromosomes
are organized, or how the metabolic activi-
ties that take place within the nucleus re-
late to the substructures that are revealed by
fluorescence and electron microscopy. A
major question is to what extent nuclear
substructure arises transiently as a conse-
quence of activities such as transcription
and replication, and to what extent it re-
flects the assembly of dedicated “factories”
at specific sites in the nucleus (which in
turn impose constraints on the location of
replication, transcription, and RNA pro-
cessing events).
The nucleus is a highly dynamic or-
ganelle in which the assembly of compart-
ments in response to metabolic require-
ments of the cell may be a general feature,
because many factors appear able to equil-
ibrate between a free nucleoplasmic pool
and assembly into large structures. Al-
though nuclear bodies may have more sim-
ilarity to cytoplasmic structures such as
the mitotic spindle and Golgi apparatus
than to long-lived organelles such as mi-
tochondria, this does not lessen the poten-
tial importance to the cell of using large
organizing structures to bring together
molecules of related function that will
consequently enhance the efficiency of
nuclear processes. The currently available
data lend support to the view that a nu-
cleus is far from a randomly arranged bag
of molecules, but rather functions as an
integrated and highly ordered machine,
albeit one with a high degree of built-in
structural flexibility. We are confident
that future studies will illuminate the basic
principles underlying nuclear organization
and will increase our understanding of
how disruptions of this organization con-
tribute to human disease.
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